|
ZNF24 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.94669996683916E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.99170000386917E-08 |
| Normal-vs-Stage2 |
2.24529999999223E-05 |
| Normal-vs-Stage3 |
3.9568999999906E-06 |
| Normal-vs-Stage4 |
1.17340000049815E-07 |
| Stage1-vs-Stage2 |
9.639200E-01 |
| Stage1-vs-Stage3 |
3.402600E-01 |
| Stage1-vs-Stage4 |
3.814500E-02 |
| Stage2-vs-Stage3 |
3.756200E-01 |
| Stage2-vs-Stage4 |
5.884200E-02 |
| Stage3-vs-Stage4 |
4.048800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.98429997064909E-09 |
| Normal-vs-AfricanAmerican |
1.24830000003406E-07 |
| Normal-vs-Asian |
1.77780001830996E-09 |
| Caucasian-vs-AfricanAmerican |
8.364000E-01 |
| Caucasian-vs-Asian |
3.644600E-04 |
| AfricanAmerican-vs-Asian |
9.617300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.12589962195398E-10 |
| Normal-vs-Female |
6.190500E-04 |
| Male-vs-Female |
5.475500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.68159999999996E-05 |
| Normal-vs-Extreme_Weight |
7.43350003773458E-09 |
| Normal-vs-Obese |
4.7696000005093E-07 |
| Normal-vs-Extreme_Obese |
2.958900E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.067800E-01 |
| Normal_Weight-vs-Obese |
8.386800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.536600E-01 |
| Extreme_Weight-vs-Obese |
3.267600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.789600E-01 |
| Obese-vs-Extreme_Obese |
8.128800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.77920000002485E-06 |
| Normal-vs-Age(41-60Yrs) |
2.09369999999431E-05 |
| Normal-vs-Age(61-80Yrs) |
2.30140018153691E-10 |
| Normal-vs-Age(81-100Yrs) |
2.52450000004512E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.631800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.372400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.869200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.030300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.481240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.574000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.511100000684E-08 |
| Normal-VS-Type2 PRCC |
5.10160003130977E-09 |
| Normal-VS-KIRP CIMP |
6.35329999720824E-08 |
| Normal-VS-Unclassified PRCC |
4.223300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.451420E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.822100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.444800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.064000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.889410E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.178000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.53980228146634E-11 |
| Normal-vs-N1 |
2.43060000015838E-07 |
| Normal-vs-N2 |
2.23769999999623E-05 |
| N0-vs-N1 |
7.496200E-01 |
| N0-vs-N2 |
2.284000E-01 |
| N1-vs-N2 |
2.217000E-01 |
|
|
